5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 safety lead-in and randomized open-label perioperative study of vorasidenib combined with pembrolizumab in recurrent or progressive enhancing IDH1-mutant astrocytomas: Safety lead-in results
    Meeting Abstract

    Wen, P.; Peters, K.; de la Fuente, M.; Mellinghoff, I.; Arrillaga-Romany, I.; Kumthekar, P.; Clarke, J.; Puduvalli, V.; de Groot, J.; Zhang, X. M.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Public tumor-wide neoantigens derived from clonal aberrant splicing events drive tumor-specific T-cell responses
    Meeting Abstract

    Kwok, D.; Stevers, N.; Nejo, T.; Jung, J.; Chen, L.; Lakshmanachetty, S.; Etxeberria, I.; Gallus, M.; Yamamichi, A.; Ramos, E.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Evolving survival in patients with leptomeningeal metastases from solid tumors
    Meeting Abstract

    Chabot, K.; Osei-Gyening, I.; Estrera, R.; Yang, J.; Pentsova, E.; Boire, A.; Wilcox, J.
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Results of safety lead in of phase IL trial of combination olaparib, temozolomide, and pembrolizumab for patients with IDH-mutant glioma
    Meeting Abstract

    Fortunato, J.; Newton, A.; Gonzalez, A.; Gavrilovic, I.; Miller, A.; Grommes, C.; Lin, A.; Pentsova, E.; Mellinghoff, I.; Kaley, T.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Droplet digital PCR enhances detection of hotspot mutations in circulating tumor DNA from cerebrospinal fluid of patients with high-grade glioma
    Meeting Abstract

    Tartaro, M.; Nandakumar, S.; Hertz, C. A.; Holle, B.; Hill, K.; Lapshina, M.; Farina, A.; Arcila, M.; Miller, A.; Mellinghoff, I.
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Modeling reversible tumorigenesis in cerebral organoids
    Meeting Abstract

    Graham, M.; Codega, P.; Campos, C.; Nandakumar, S.; Rosenblum, M.; Antonescu, C.; Grogan, M.; Benhamida, J.; Bale, T.; von Deimling, A.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: Pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response
    Meeting Abstract

    Imber, B.; Ravichandran, V.; Rao, P.; Casanova, H.; Friend, J.; Simpson, J.; Pike, L.; Zinovoy, M.; Mitchell, R.; Chacko, C.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Tumor volume growth rates and doubling times during active surveillance of IDH-mutant low-grade glioma
    Meeting Abstract

    Bhatia, A.; Moreno, R.; Reiner, A.; Nandakumar, S.; Walch, H.; Thomas, T.; Nicklin, P.; Choi, C.; Skakodub, A.; Malani, R.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Genomic characteristics and clinical outcomes of stereotactic radiosurgery for colorectal cancer brain metastases
    Meeting Abstract

    Gui, C.; Walch, H.; Mueller, K.; Eichholz, J.; Khatri, I.; Del Balzo, L.; Kemeny, N.; Imber, B.; Schultz, N.; Foote, M.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • The genomic landscape of brain metastasis
    Meeting Abstract

    Skakodub, A.; Walch, H.; Kumar, R.; Eichholz, J.; Cooper, C.; Khatri, I.; Del Balzo, L.; Miao, E.; Gui, C.; Ma, J.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save